18th Sep 2009 17:46
Notifiable share interest in Algeta ASA
GlaxoSmithKline plc (GSK) announces that on 18 September 2009 S.R. One, Limited, a wholly owned US-registered subsidiary of GSK, sold 274,800 ordinary shares of Algeta ASA ("Algeta"), an oncology company located in Norway and whose shares are traded on the Oslo Børs (Oslo Stock Exchange).
GSK's interest, which is held entirely by S.R. One, Limited, now comprises 1,697,800 ordinary shares or 4.313% of Algeta AGA. The calculation is based on a total of 39,351,082 ordinary shares outstanding in Algeta. This decrease in GSK's holding became disclosable under the Norwegian Securities Trading Act upon falling below 5% of the issued share capital of Algeta.
Simon M Bicknell
Company Secretary
18 September 2009
Related Shares:
Glaxosmithkline